APA (7th ed.) Citation

JL, C., MP, S., MA, P., JR, O. O., DG, W., SA, M., . . . ML, H. (2023). Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach. Molecular therapy. Nucleic acids, 33, 15. https://doi.org/10.1016/j.omtn.2023.05.025

Chicago Style (17th ed.) Citation

JL, Centa, Stratton MP, Pratt MA, Osterlund Oltmanns JR, Wallace DG, Miller SA, Weimer JM, and Hastings ML. "Protracted CLN3 Batten Disease in Mice That Genetically Model an Exon-skipping Therapeutic Approach." Molecular Therapy. Nucleic Acids 33 (2023): 15. https://doi.org/10.1016/j.omtn.2023.05.025.

MLA (9th ed.) Citation

JL, Centa, et al. "Protracted CLN3 Batten Disease in Mice That Genetically Model an Exon-skipping Therapeutic Approach." Molecular Therapy. Nucleic Acids, vol. 33, 2023, p. 15, https://doi.org/10.1016/j.omtn.2023.05.025.